328 related articles for article (PubMed ID: 30140845)
1. Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder: A Review.
Dougherty DD; Brennan BP; Stewart SE; Wilhelm S; Widge AS; Rauch SL
JAMA Psychiatry; 2018 Oct; 75(10):1081-1087. PubMed ID: 30140845
[TBL] [Abstract][Full Text] [Related]
2. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit.
Milad MR; Furtak SC; Greenberg JL; Keshaviah A; Im JJ; Falkenstein MJ; Jenike M; Rauch SL; Wilhelm S
JAMA Psychiatry; 2013 Jun; 70(6):608-18; quiz 554. PubMed ID: 23740049
[TBL] [Abstract][Full Text] [Related]
3. Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery.
McGovern RA; Sheth SA
J Neurosurg; 2017 Jan; 126(1):132-147. PubMed ID: 27035167
[TBL] [Abstract][Full Text] [Related]
4. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder.
Goodman WK; Storch EA; Sheth SA
Am J Psychiatry; 2021 Jan; 178(1):17-29. PubMed ID: 33384007
[TBL] [Abstract][Full Text] [Related]
5. Learning From Animal Models of Obsessive-Compulsive Disorder.
Monteiro P; Feng G
Biol Psychiatry; 2016 Jan; 79(1):7-16. PubMed ID: 26037910
[TBL] [Abstract][Full Text] [Related]
6. Outlining new frontiers for the comprehension of obsessive-compulsive disorder: a review of its relationship with fear and anxiety.
Diniz JB; Miguel EC; de Oliveira AR; Reimer AE; Brandão ML; de Mathis MA; Batistuzzo MC; Costa DL; Hoexter MQ
Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S81-91. PubMed ID: 22729451
[TBL] [Abstract][Full Text] [Related]
7. Neuromodulation for obsessive-compulsive disorder.
Lapidus KA; Stern ER; Berlin HA; Goodman WK
Neurotherapeutics; 2014 Jul; 11(3):485-95. PubMed ID: 24981434
[TBL] [Abstract][Full Text] [Related]
8. FEAR CONDITIONING AND EXTINCTION IN YOUTH WITH OBSESSIVE-COMPULSIVE DISORDER.
McGuire JF; Orr SP; Wu MS; Lewin AB; Small BJ; Phares V; Murphy TK; Wilhelm S; Pine DS; Geller D; Storch EA
Depress Anxiety; 2016 Mar; 33(3):229-37. PubMed ID: 26799264
[TBL] [Abstract][Full Text] [Related]
9. Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study.
Giménez M; Cano M; Martínez-Zalacaín I; Real E; Alonso P; Segalàs C; Munuera J; Kegeles LS; Weinstein JJ; Xu X; Menchón JM; Cardoner N; Soriano-Mas C; Fullana MA
Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):1003-1014. PubMed ID: 31432262
[TBL] [Abstract][Full Text] [Related]
10. Neuromodulation in obsessive-compulsive disorder.
Bais M; Figee M; Denys D
Psychiatr Clin North Am; 2014 Sep; 37(3):393-413. PubMed ID: 25150569
[TBL] [Abstract][Full Text] [Related]
11. Fear extinction in an obsessive-compulsive disorder animal model: Influence of sex and estrous cycle.
Reimer AE; de Oliveira AR; Diniz JB; Hoexter MQ; Miguel EC; Milad MR; Brandão ML
Neuropharmacology; 2018 Mar; 131():104-115. PubMed ID: 29225044
[TBL] [Abstract][Full Text] [Related]
12. The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder.
Coenen VA; Schlaepfer TE; Goll P; Reinacher PC; Voderholzer U; Tebartz van Elst L; Urbach H; Freyer T
CNS Spectr; 2017 Jun; 22(3):282-289. PubMed ID: 27268576
[TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation in obsessive-compulsive disorder: neurocircuitry and clinical experience.
Lipsman N; Giacobbe P; Lozano AM
Handb Clin Neurol; 2013; 116():245-50. PubMed ID: 24112898
[TBL] [Abstract][Full Text] [Related]
14. The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder.
Acevedo N; Castle D; Rossell S
Expert Rev Neurother; 2024 Feb; 24(2):145-158. PubMed ID: 38247445
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder: An Educational Review.
Ross DA; Arbuckle MR; Travis MJ; Dwyer JB; van Schalkwyk GI; Ressler KJ
JAMA Psychiatry; 2017 Apr; 74(4):407-415. PubMed ID: 28273291
[TBL] [Abstract][Full Text] [Related]
16. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
Matsunaga H
Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
[TBL] [Abstract][Full Text] [Related]
17. Device-based brain stimulation to augment fear extinction: implications for PTSD treatment and beyond.
Marin MF; Camprodon JA; Dougherty DD; Milad MR
Depress Anxiety; 2014 Apr; 31(4):269-78. PubMed ID: 24634247
[TBL] [Abstract][Full Text] [Related]
18. Somatic treatments excluding psychopharmacology in obsessive- compulsive disorder: a review.
Atmaca M
Rev Recent Clin Trials; 2013 Jun; 8(2):119-23. PubMed ID: 24032546
[TBL] [Abstract][Full Text] [Related]
19. Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: a morphometric study.
Fullana MA; Cardoner N; Alonso P; Subirà M; López-Solà C; Pujol J; Segalàs C; Real E; Bossa M; Zacur E; Martínez-Zalacaín I; Bulbena A; Menchón JM; Olmos S; Soriano-Mas C
Psychol Med; 2014 Mar; 44(4):845-56. PubMed ID: 23773479
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear.
Rodriguez-Romaguera J; Do Monte FH; Quirk GJ
Proc Natl Acad Sci U S A; 2012 May; 109(22):8764-9. PubMed ID: 22586125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
